Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

BACKGROUND: Circulating tumour DNA (ctDNA) may serve as a measure of tumour burden and a useful tool for non-invasive monitoring of cancer. However, ctDNA is not always detectable in patients at time of diagnosis of metastatic disease. Therefore, there is a need to understand the correlation between...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: McEvoy, Ashleigh C., Warburton, Lydia, Al-Ogaili, Zeyad, Celliers, Liesl, Calapre, Leslie, Pereira, Michelle R., Khattak, Muhammad A., Meniawy, Tarek M., Millward, Michael, Ziman, Melanie, Gray, Elin S.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6038195/
https://ncbi.nlm.nih.gov/pubmed/29986670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4637-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados